Protalix BioTherapeutics
PLX
#8567
Rank
โ‚ฌ0.11 B
Marketcap
1,61ย โ‚ฌ
Share price
1.81%
Change (1 day)
23.03%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ60.09 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are โ‚ฌ60.09 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ46.01 M-25.7%
2022-12-31โ‚ฌ61.92 M-12.01%
2021-12-31โ‚ฌ70.37 M-8.85%
2020-12-31โ‚ฌ77.21 M-25.25%
2019-12-31โ‚ฌ0.10 B3.65%
2018-12-31โ‚ฌ99.66 M17.61%
2017-12-31โ‚ฌ84.73 M-3.33%
2016-12-31โ‚ฌ87.65 M10.96%
2015-12-31โ‚ฌ79 M-28.27%
2014-12-31โ‚ฌ0.11 B8.43%
2013-12-31โ‚ฌ0.10 B63.69%
2012-12-31โ‚ฌ62.05 M3.47%
2011-12-31โ‚ฌ59.97 M4.89%
2010-12-31โ‚ฌ57.17 M-1.05%
2009-12-31โ‚ฌ57.78 M1149.73%
2008-12-31โ‚ฌ4.62 M51.64%
2007-12-31โ‚ฌ3.04 M48.79%
2006-12-31โ‚ฌ2.04 M114.83%
2005-12-31โ‚ฌ0.95 M1722.51%
2004-12-31โ‚ฌ0.05 M-16.4%
2003-12-31โ‚ฌ0.06 M-17.23%
2002-12-31โ‚ฌ0.07 M-13.55%
2001-12-31โ‚ฌ0.08 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.58 B 865.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.77 B 1,196.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ121.14 B 201,488.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ33.76 B 56,085.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel